Given the widely accepted evidence that Type 1 diabetes is an auto-immune disease, then, if A1 beta-casein is a causal factor, it is logical that the antigen has to be the difference between the two beta-caseins in relation to the release of bBCM7. This evidence concerns the gene CSN2 and type 1 diabetes mellitus.